Moderna

Principal HRIS Analyst

Cambridge, Massachusetts, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Human Resources, Information TechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Information Systems, Human Resources, or a related field, and a minimum of 7 years of hands-on Workday configuration and solution delivery experience. They should also hold a Workday Pro or former Workday implementer certification, ideally in Payroll, Time Tracking, Absence, and Advanced Reporting, with additional certifications in Core HCM and Compensation being a plus. Furthermore, candidates must have experience supporting global Workday environments and understanding multi-country regulatory requirements.

Responsibilities

As a Principal HRIS Analyst, the role involves leading the design, configuration, and continuous improvement of Workday solutions for Payroll, Time Tracking, Absence, and Compensation, serving as a functional and technical subject matter expert, supporting cross-functional initiatives, driving continuous improvement, ensuring scalable configurations, owning Workday release management, advising stakeholders, managing work independently, collaborating across HR, IT, and business functions, and communicating effectively on timelines and outcomes.

Skills

Workday
Payroll
Time Tracking
Absence Management
Compensation
HCM
Reporting
Configuration
Release Management
Global Workday
Multi-Country Regulations

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Key Metrics

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI